Transgenic mouse model of ethanol as a cofactor in HIV disease

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 5 SUPPL., 1998, Pages

  Prakash, O ^a   Joshi, B H ^a   Zhang, P ^b   Aw, T Y ^c   Teng, S ^a   Ali, M ^a   Shellito, J E ^b   Nelson, S ^b  

^a OCHSNER MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; CONFERENCE PAPER; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 0031682069     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb04015.x     Document Type: Conference Paper

References (39)

1. Pantaleo G, Fauci AS: Immunopathogenesis of HIV infection. Annu Rev Microbiol 50:825-854, 1996
2. Bagasra O, Kajdacsy-Balla A, Lischner HW: Effects of alcohol ingestion on in vivo susceptibility of peripheral blood mononuclear cells to infection with HIV-1 on selected T-cell functions. Alcohol Clin Exp Res 13:636-643, 1989
3. Balla AK, Lischner HW, Pomerantz RJ, Bagasra O: Human studies on alcohol and susceptibility to HIV infection. Alcohol 11:99-103, 1994
4. MacGregor RR: Alcohol and immune defense. JAMA 256:1474-1479, 1986
5. Siegel L: AIDS: Relationship to alcohol and other drugs. J Subst Abuse Treat 3:271-274, 1986
6. Sararolatz LD, Cerra RE, Phlod DJ, Smereck S: The effect of alcohol on HIV-1 infection in vitro, in Seminara A, Watson RR, Pawlowski D (eds): Alcohol, Immunomodulation and AIDS. New York, Alan R. Liss, 1990, p 267
7. Bagasra O, Bachman SE, Jew L, Tawadros R, Cater J, Boden G, Ryan I, Pomerantz RJ: Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: Potential immunopathogenic mechanisms. J Infect Dis 173:550-558, 1996
8. Ameisen JC: Programmed cell death and AIDS: From hypothesis to experiment. Immunol Today 13:388-391, 1992
9. Gougeon ML, Montagnier L: Apoptosis in AIDS. Science 260: 1269-1270, 1993
10. Jerrells T, Eckardt M, Weinberg J: Mechanisms of ethanol-induced immunosuppression, in Seminara D, Watson R, Pawlowski A (eds): Alcohol, Immunomodulation, and AIDS. New York, Alan R. Liss, 1990, p 173
11. Ewald SJ, Shao H: Ethanol increases apoptotic cell death of thymocytes in vitro. Alcohol Clin Exp Res 17:359-365, 1993
12. Baruchel S, Wainberg MA: The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukoc Biol 52:111-114, 1992
13. Halliwell B, Cross CE: Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Arch Intern Med 151:29-31, 1991
14. Pace GW, Leaf CD: The role of oxidative stress in HIV disease. Free Radic Biol Med 19:523-528, 1995
15. Nordmann R, Ribiére C, Rouach H: Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med 12:219-240, 1992
16. Montoliu C, Vallés S, Renau-Piqueras J, Guerri C: Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: Effect of chronic alcohol consumption. J Neurochem 63:1855-1862, 1994
17. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534, 1996
18. Chen GJ, Huang DS, Watzl B, Watson RR: Ethanol modulation of tumor necrosis factor and gamma interferon production by murine splenocytes and macrophages. Life Sci 52:1319-1326, 1993
19. Wagner F, Fink R, Hart R, Lersch C, Dancygier H, Classen M: Ethanol inhibits interferon-gamma secretion by human peripheral lymphocytes. J Stud Alcohol 53:277-280, 1992
20. Steinberg HN, Crumpacker CS, Chatis PA: In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 65:1765-1769, 1991
21. Tisman G, Herbert V: In vitro myelosuppression and immunosuppression by ethanol. J Clin Invest 52:1410-1414, 1973
22. Levy JA: HIV Infection and Development of Cancer, HIV and the Pathogenesis of AIDS. Washington, DC, ASM Press, 1994, p 181
23. Longnecker MP: Alcohol consumption and risk of cancer in humans: An overview. Alcohol 12:87-96, 1995
24. Arya SK, Guo C, Josephs SF, Wong-Staal F: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69-73, 1985
25. Fisher AG, Feinberg MB, Josephs SF, Harper ME, Marselle G, Reyes MA, Gonda MA, Aldovini A, Debouk C, Gallo RC, Wong-Staal F: The trans-activator gene of HTLV-III is essential for virus replication. Nature (Lond) 320:367-371, 1986
26. Sodroski J, Patarca R, Rosen C, Wong-Staal F, Haseltine W: Location of the transactivating region on the genome of human T-cell lymphotropic virus type III. Science 229:74-77, 1985
27. Tiley LS, Brown PH, Cullen BR: Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain? Virology 178:560-567, 1990
28. Brake DA, Debouck C, Biesecker G: Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J Cell Biol 111:1275-1281, 1990
29. Chang H-K, Gallo RC, Ensoli B: Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J Biomed Sci 2:189-202, 1995
30. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM: Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 90:7632-7636, 1993
31. Prakash O, Teng S, Ali M, Zhu X, Coleman R, Dabdoub RA, Chambers R, Aw TY, Flores SC, Joshi BH: The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Arch Biochem Biophys 343:173-180, 1997
32. 72-transgenic mice. J Immunol 156:3631-3637, 1996
33. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S: HIV-1 Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. J Immunol 156:1638-1645, 1996
34. Viscidi RP, Mayur K, Lederman HM, Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606-1608, 1989
35. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin K-M, Krammer PH: Sensitization of T cell to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500, 1995
36. Denis M: Tat protein from HIV-1 binds to Mycobacterum avium via a bacterial integrin. J Immunol 153:2072-2081, 1994
37. Doweiko JP, Groopman JE: The hematological consequences of HIV infection, in Broder S, Merigan TC, Bolognesi D (eds): Textbook of AIDS Medicine. Baltimore, Williams & Wilkins, 1994, p 617
38. Leiderman IZ, Greenberg ML, Adelsberg BR, Siegel FP: A glycoprotein inhibitor or in vitro granulopoiesis associated with AIDS. Blood 70:1267-1272, 1987
39. Shyur S-D, Hill HR: Polymorphonuclear leukocyte function in HIV, in Gupta S (ed): Immunology of HIV Infection. New York, Plenum Publishing Corporation, 1986, p 377